IMC Chicago
REGN icon

IMC Chicago’s Regeneron Pharmaceuticals REGN Stock Holding History

IMC Chicago’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110M Sell
142,600
-87,300
-38% -$66.8M 0.04% 277
2025
Q4 		$177M Buy
229,900
+25,800
+13% +$17.5M 0.06% 184
2025
Q3 		$115M Buy
204,100
+75,800
+59% +$42.9M 0.04% 249
2025
Q2 		$67.4M Buy
128,300
+54,600
+74% +$30.5M 0.03% 319
2025
Q1 		$46.7M Buy
73,700
+28,200
+62% +$19.4M 0.03% 339
2024
Q4 		$32.4M Buy
+45,500
New +$38.2M 0.02% 450
2024
Q2 		– Sell
-16,500
Closed -$15.9M – 2756
2024
Q1 		$15.9M Buy
16,500
+5,000
+43% +$4.75M 0.01% 540
2023
Q4 		$10.1M Sell
11,500
-15,000
-57% -$12.4M 0.01% 644
2023
Q3 		$21.8M Sell
26,500
-32,900
-55% -$25.9M 0.02% 359
2023
Q2 		$42.7M Buy
59,400
+34,500
+139% +$26.6M 0.04% 219
2023
Q1 		$20.5M Buy
24,900
+8,100
+48% +$6.11M 0.02% 327
2022
Q4 		$12.1M Sell
16,800
-4,300
-20% -$3.17M 0.02% 422
2022
Q3 		$14.5M Buy
+21,100
New +$13.3M 0.02% 365
2022
Q1 		– Sell
-18,800
Closed -$11.9M – 1207
2021
Q4 		$11.9M Sell
18,800
-19,500
-51% -$12M 0.01% 460
2021
Q3 		$23.2M Buy
38,300
+17,200
+82% +$10.7M 0.02% 332
2021
Q2 		$11.8M Sell
21,100
-13,700
-39% -$6.94M 0.01% 425
2021
Q1 		$16.5M Sell
34,800
-78,800
-69% -$38.4M 0.02% 331
2020
Q4 		$54.9M Buy
113,600
+77,900
+218% +$42.1M 0.07% 122
2020
Q3 		$20M Buy
35,700
+6,200
+21% +$3.76M 0.03% 205
2020
Q2 		$18.4M Sell
29,500
-20,600
-41% -$11.7M 0.04% 172
2020
Q1 		$24.5M Buy
50,100
+15,300
+44% +$6.31M 0.05% 123
2019
Q4 		$13.1M Buy
34,800
+19,000
+120% +$6.39M 0.03% 180
2019
Q3 		$4.38M Sell
15,800
-16,800
-52% -$4.97M 0.01% 306
2019
Q2 		$10.2M Buy
32,600
+16,600
+104% +$5.53M 0.03% 171
2019
Q1 		$6.57M Sell
16,000
-4,900
-23% -$2.02M 0.02% 202
2018
Q4 		$7.81M Buy
+20,900
New +$7.65M 0.02% 140

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IMC Chicago's REGN Position: Q3 2025 in Review

IMC Chicago sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 17,952 shares — an estimated $10.2M sold.

IMC Chicago first reported a position in REGN in Q2 2025 and held it in 1 quarter. The position peaked at $9.42M in Q2 2025. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • IMC Chicago reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • IMC Chicago sold 17,952 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $10.2M.
  • IMC Chicago first reported a position in Regeneron Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • IMC Chicago's Regeneron Pharmaceuticals position peaked at $9.42M in Q2 2025.
  • 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on IMC Chicago's 13F filing for Q3 2025, filed 4 Nov 2025.